Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07805694
Starting soon Observational

Neurovascular Unit for Aged Patients With Geriatric Care and Evaluation of Factors Associated With Autonomy Loss

NCT07805694 · tracked via the Priya Life Science France tracker
Sponsor
Hospices Civils de Lyon
Phase
Observational
Started
2026-12-15
Last updated
2026-09-04

Condition(s) studied

Stroke

Investigational drug(s) / intervention(s)

Not applicable- observational study

Not applicable- observational study: not applicable - observational study

Study summary

There are few neurovascular units (short stay and MRS (medical and rehabilitation service)) dedicated to the care of older people after a stroke in France and around the world. The geriatric medicine department at Charpennes Hospital developed this unit more than 20 years ago, giving it unique experience and expertise acquired over many years. However, to date, the profiles of patients included in these units and the factors associated with loss of independence and the outcomes of older patients hospitalized in neurovascular units for older adults remain unknown. In this context, the NUAGE study aims to describe the population cared for in this unit and analyze the factors associated with patient outcomes.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * \- Patients over 65 years of age * Hospitalized for short-term medical-surgical care in geriatrics or MRS (medical and rehabilitation service) in the neurovascular unit for the elderly (4AC) at Charpennes Hospital, HCL Villeurbanne Exclusion Criteria: * \- Patients, relatives/trusted individuals, legal representatives who object to the research

Primary outcome measure(s)

  • Describe the characteristics of hospitalized patients and their outcomes in the geriatric neurovascular unit at Hôpital des Charpennes (short stay and MRS). — Data will be collected on the day of admission (day 1 of the patient's hospitalization) and on the day of his/her discharge from the neurovascular unit.
    The following data will be collected to describe the characteristics of the study population : Age (years) Gender (F/M) IMC (kg/m²) Smoking/alcohol consumption Comorbidities (Charlson score) Presence/Absence of Hypertension, DiabetesTreatment Type of stroke (ischemic or hemorrhagic) + Artery involved Complications related to treatment (falls, spastic pain, swallowing disorders, malnutrition, infections, bedsores, epilepsy) Biological parameters (cholesterol (g/L), albumin (g/L)) Cognitive and cardiovascular assessments related to stroke assessment (cardiac ultrasound, arterial Doppler ultrasound, radiocinema) National Institutes of Health Stroke Scale (NIHSS) Modified Rankin Scale (mRS) Measure of functional independence (MIF) Type of discharge (death, institutionalization, return home)

Trial sites (1)

FacilityCityRegionStatus
Hôpital des Charpennes (Hospices Civils de Lyon) Villeurbanne France

More Hospices Civils de Lyon trials in France

Non-invasive Personalized Transcranial Cortical Neurostimulation for Pain Relief Recruiting
Validation of the French Version of the New Mobility Score (NMS) Recruiting
Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts Recruiting
Impact of Mental Health First Aid-trained Peers on the Mental Well-being of First-year Medical Residents. Active, not recruiting
Psychological Support Interventions for Women With Endometriosis (ENDOPSY) Starting soon

Other trials for the same condition

Sensory Mechanisms of Manual Dexterity Recovery After Stroke: a Prospective Cohort Study of Prediction and Cerebral Correlates Starting soon
Genetic Variants of Annexin A2 and Cryptogenic Stroke Recruiting
Addiction & Stroke Recruiting
Fine Motor Skills and Post-Stroke Swallowing Active, not recruiting
Cerebello-motor Neuromodulation After Stroke. CERSTIM. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07805694 on ClinicalTrials.gov ↗ ← All trials in France